» Articles » PMID: 31972332

The Impact of Size and Surface Ligand of Gold Nanorods on Liver Cancer Accumulation and Photothermal Therapy in the Second Near-infrared Window

Overview
Specialty Chemistry
Date 2020 Jan 24
PMID 31972332
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gold nanorods (GNRs) with longitudinal surface plasmon resonance (LSPR) peaks in second near-infrared (NIR-II) window have attracted a great amount of attention as photothermal transducer because of their inherently excellent photothermal transition efficiency, high biocompatibility and versatile surface functionalization. One key question for the application of these GNRs against tumors in vivo is which size/shape and surface ligand conjugation are promising for circulation and tumor targeting. In this study, we prepared a series of gold nanorods (GNRs) of similar aspect ratio and LSPR peaks, and thus similar photothermal transfer efficiency under irradiation of 980 nm laser, but with tunable size in width and length. The obtained GNRs were subjected to surface modification with PEG and tumor targeting ligand lactoferrin. With these tailor-designed GNRs in hand, we have the chance to study the impact of dimension and surface property of the GNRs on their internalization via tumor cells, photothermal cytotoxicity in vitro, blood circulation and tissue distribution pattern in vivo. As a result, the GNRs with medium size (70 nm in length and 11.5 nm in width) and surface PEG/LF modification (GNR70@PEG-LF) exhibit the fastest cell internalization via HepG2 cells and best photothermal outcome in vitro. The GNR70@PEG-LF also display long circulation time and the highest tumor accumulation in vivo, due to the synergetic effect of surface coating and dimension. Finally, tumor ablation ability of the GNRs under irradiation of 980 nm light were validated on mice xenograft model, suggesting their potential photothermal therapy against cancer in NIR-II window.

Citing Articles

Photoresponsive Inorganic Nanomaterials in Oncology.

Barbero F, Gul S, Perrone G, Fenoglio I Technol Cancer Res Treat. 2023; 22:15330338231192850.

PMID: 37551087 PMC: 10408349. DOI: 10.1177/15330338231192850.


Nanomaterial-based CT contrast agents and their applications in image-guided therapy.

Jiang Z, Zhang M, Li P, Wang Y, Fu Q Theranostics. 2023; 13(2):483-509.

PMID: 36632234 PMC: 9830442. DOI: 10.7150/thno.79625.


Thermal and Medium Stability Study of Polyvidone-Modified Graphene Oxide-Coated Gold Nanorods with High Photothermal Efficiency.

Lebepe T, Oluwafemi O Nanomaterials (Basel). 2022; 12(19).

PMID: 36234510 PMC: 9565574. DOI: 10.3390/nano12193382.


Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives.

Alle M, Sharma G, Lee S, Kim J J Nanobiotechnology. 2022; 20(1):222.

PMID: 35778747 PMC: 9250257. DOI: 10.1186/s12951-022-01402-z.


Gold Nanorod-Assisted Photothermal Therapy and Improvement Strategies.

Taylor M, Wilson Jr R, Amrhein K, Huang X Bioengineering (Basel). 2022; 9(5).

PMID: 35621478 PMC: 9138169. DOI: 10.3390/bioengineering9050200.